INVASIVE EXTRAINTESTINAL PATHOGENIC ESCHERICHIA COLI DISEASE (IED) PREVENTION
Clinical trials for INVASIVE EXTRAINTESTINAL PATHOGENIC ESCHERICHIA COLI DISEASE (IED) PREVENTION explained in plain language.
Never miss a new study
Get alerted when new INVASIVE EXTRAINTESTINAL PATHOGENIC ESCHERICHIA COLI DISEASE (IED) PREVENTION trials appear
Sign up with your email to follow new studies for INVASIVE EXTRAINTESTINAL PATHOGENIC ESCHERICHIA COLI DISEASE (IED) PREVENTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Major vaccine trial aims to shield seniors from dangerous e. coli infections
⭐️ VACCINE ⭐️ CompletedThis large, completed Phase 3 study tested whether a new 9-valent vaccine (ExPEC9V) could prevent serious, invasive E. coli infections in adults aged 60 and older who had a urinary tract infection in the past two years. Over 17,900 participants received either the vaccine or a pl…
Matched conditions: INVASIVE EXTRAINTESTINAL PATHOGENIC ESCHERICHIA COLI DISEASE (IED) PREVENTION
Phase: PHASE3 • Sponsor: Janssen Research & Development, LLC • Aim: ⭐️ VACCINE ⭐️
Last updated Apr 09, 2026 19:32 UTC
-
Double vaccine study aims to shield seniors from e. coli and flu
Prevention CompletedThis study tested whether a new vaccine against a serious E. coli infection (ExPEC9V) can be given at the same time as the high-dose flu shot in adults 65 and older. About 959 volunteers received either both vaccines together or separately to check if the immune response stays st…
Matched conditions: INVASIVE EXTRAINTESTINAL PATHOGENIC ESCHERICHIA COLI DISEASE (IED) PREVENTION
Phase: PHASE3 • Sponsor: Janssen Research & Development, LLC • Aim: Prevention
Last updated May 07, 2026 18:40 UTC